[Recommendations for the patient during the treatment of colorectal cancer through the enhanced recovery.]

Pere Planellas Giné, Ernest Castro Gutiérrez, Lidia Cornejo, Ramon Farrés Coll

Abstract readEnglish Abstract

In one paragraph

Article in Revista espanola de salud publica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Pere Planellas GinéUnidad de Cirugía Colorrectal, Departamento de Cirugía General y Digestiva, Hospital Universitario de Girona. Departamento de Ciencias Médicas, Facultad de Medicina, Universidad de Girona, Instituto de Investigación Biomédica de Girona (IDIBGI). Girona. España.

Ernest Castro GutiérrezUnidad de Cirugía HepatoBilioPancreática, Departamento de Cirugía General y Digestiva, Hospital Universitario de Girona. Departamento de Ciencias Médicas, Facultad de Medicina, Universidad de Girona, Instituto de Investigación Biomédica de Girona (IDIBGI). Girona. España.

Lidia CornejoGrupo de Investigación en Cirugía General y Digestiva, Instituto de Investigación Biomédica de Girona (IDIBGI). Girona. España.

Ramon Farrés CollUnidad de Cirugía Colorrectal, Departamento de Cirugía General y Digestiva, Hospital Universitario de Girona. Departamento de Ciencias Médicas, Facultad de Medicina, Universidad de Girona, Instituto de Investigación Biomédica de Girona (IDIBGI). Girona. España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is estimated that colorectal cancer is the cancer disease with the highest incidence in Spain due to the increase in life expectancy and changes in the lifestyle of the population . Early detection through disease screening programs allows for more effective treatment and a higher survival rate . Advances in treatment have been made, such as targeted therapies, which focus on specifically attacking cancer cells and preventing their growth . However, much remains to be done in terms of prevention and treatment of colorectal cancer. More research and medical advances are required to combat this disease.

Indexed as

Colorectal NeoplasmsPatientsHumansLife ExpectancyLife StyleSpainColorectal cancerSpain

Identifiers

PMID37161836

PMCPMC10541260

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.